Interacting Drugs |
Hyoscyamine, atropine, scopolamine, and phenobarbital vs Ketorolac (Nasal) |
Security Level |
 |
Mechanism |
Ketorolac (Nasal): May diminish the therapeutic effect of Anticonvulsants. |
Management |
Monitor therapy |
Hyoscyamine, atropine, scopolamine, and phenobarbital vs Ketorolac (Nasal)
Post Review about Hyoscyamine, atropine, scopolamine, and phenobarbital vs Ketorolac (Nasal) Click here to cancel reply.
Other Interactions of Hyoscyamine, atropine, scopolamine, and phenobarbital
Other Interactions of Ketorolac (Nasal)
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.